ORPH - Orphazyme A/S - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Orphazyme A/S's activity chart (see below) currently has 4 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 30 days.

Most recent stock forecast was given by YATIN SUNEJA from GUGGENHEIM on 21-Jun-2021. First documented stock forecast 26-Oct-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Jun-2021

$27

Sell Since 30-Mar-2021

$4.66 (1370.59%)

$13

Buy Since 26-Oct-2020

$23

$22.66 (6664.71%)

$23

Show more analysts

What is ORPH (Orphazyme A/S) average time for price targets to be met?

On average it took 30 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on ORPH (Orphazyme A/S) with a proven track record?

TAZEEN AHMAD

Which analyst has the most public recommendations on ORPH (Orphazyme A/S)?

Tazeen Ahmad works at BAML and has 3 price targets and 2 ratings on ORPH

Which analyst is the currently most bullish on ORPH (Orphazyme A/S)?

Ritu Baral with highest potential upside - $22.66

Which analyst is the currently most reserved on ORPH (Orphazyme A/S)?

Yatin Suneja with lowest potential downside - -$0